Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 EUR | -18.37% | -20.79% | -73.86% |
Business Summary
Following the merger in October 2022, BioSenic SA combines the strategic positionings and strengths of Medsenic and Bone Therapeutics.
The merger also enables Biosenic SA to add to its innovative cell therapy platform and strong IP for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO.
Managers
Managers | Title | Age | Since |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-02 |
Nicco Carole
COO | Chief Operating Officer | - | 23-01-17 |
Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Yves Sagot
BRD | Director/Board Member | 60 | 23-01-26 |
Jean Stephenne
BRD | Director/Board Member | 75 | - |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 195,254,500 | 141,530,236 ( 72.49 %) | 0 | 72.49 % |
Company contact information
BioSenic SA
Bâtiment H bte 24 Rue Granbonpré 11
1435, Mont-Saint-Guibert
+32 49 309 73 66
http://www.biosenic.comGroup companies
Name | Category and Sector |
---|---|
Skeletal Cell Therapy Support SA
Skeletal Cell Therapy Support SA Pharmaceuticals: MajorHealth Technology Skeletal Cell Therapy Support SA operates a pharmaceutical products manufacturing facility. The company is headquartered in Charleroi, Belgium. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-73.86% | 3.85M | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- BIOS Stock
- Company BioSenic SA